Literature DB >> 23860657

High-throughput screening for protein tyrosine phosphatase activity modulators.

Lutz Tautz1, Eduard A Sergienko.   

Abstract

Reversible phosphorylation of proteins, principally on serine, threonine, or tyrosine residues, is central to the regulation of most aspects of eukaryotic cell function. Dysregulation of protein kinases and protein phosphatases is linked to numerous human diseases. Consequently, many efforts have been made to target these enzymes with small molecules in order to develop new therapeutic agents. While protein kinase inhibitors have been successfully brought to the market, the development of specific protein phosphatase inhibitors is still in its infancy. The largest and most diverse protein phosphatase superfamily in humans is comprised by the protein tyrosine phosphatases, a group of over 100 enzymes. Here, we describe high-throughput screening methods to search for protein tyrosine phosphatase activity modulators. We illustrate the implementation of relatively simple phosphatase assays, using generic absorbance- or fluorescence-based substrates, in 384- or 1536-well microtiter plates. We discuss steps to optimize HTS assay quality and performance, and describe several PTP screening methods on the basis of previously performed successful HTS campaigns. Finally, we discuss how to confirm, follow up, and prioritize hit compounds, and point out a number of common pitfalls that are encountered in this process.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23860657      PMCID: PMC8148610          DOI: 10.1007/978-1-62703-562-0_14

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  37 in total

Review 1.  Signaling--2000 and beyond.

Authors:  T Hunter
Journal:  Cell       Date:  2000-01-07       Impact factor: 41.582

2.  A detergent-based assay for the detection of promiscuous inhibitors.

Authors:  Brian Y Feng; Brian K Shoichet
Journal:  Nat Protoc       Date:  2006       Impact factor: 13.491

3.  Strategies for developing protein tyrosine phosphatase inhibitors.

Authors:  Lutz Tautz; Tomas Mustelin
Journal:  Methods       Date:  2007-07       Impact factor: 3.608

Review 4.  Protein tyrosine phosphatases as drug targets: strategies and challenges of inhibitor development.

Authors:  Alastair J Barr
Journal:  Future Med Chem       Date:  2010-10       Impact factor: 3.808

5.  Transforming gene product of Rous sarcoma virus phosphorylates tyrosine.

Authors:  T Hunter; B M Sefton
Journal:  Proc Natl Acad Sci U S A       Date:  1980-03       Impact factor: 11.205

Review 6.  Inside the human cancer tyrosine phosphatome.

Authors:  Sofi G Julien; Nadia Dubé; Serge Hardy; Michel L Tremblay
Journal:  Nat Rev Cancer       Date:  2011-01       Impact factor: 60.716

Review 7.  Nonreceptor protein-tyrosine phosphatases in immune cell signaling.

Authors:  Lily I Pao; Karen Badour; Katherine A Siminovitch; Benjamin G Neel
Journal:  Annu Rev Immunol       Date:  2007       Impact factor: 28.527

Review 8.  Protein tyrosine phosphatases: emerging regulators of apoptosis.

Authors:  Maxime Hallé; Michel L Tremblay; Tzu-Ching Meng
Journal:  Cell Cycle       Date:  2007-08-19       Impact factor: 4.534

Review 9.  Tyrosine phosphorylation: thirty years and counting.

Authors:  Tony Hunter
Journal:  Curr Opin Cell Biol       Date:  2009-03-09       Impact factor: 8.382

10.  Discovery of a novel submicromolar inhibitor of the lymphoid specific tyrosine phosphatase.

Authors:  Yuli Xie; Yidong Liu; Gangli Gong; Alison Rinderspacher; Shi-Xian Deng; Deborah H Smith; Udo Toebben; Effie Tzilianos; Lars Branden; Dusica Vidović; Caty Chung; Stephan Schürer; Lutz Tautz; Donald W Landry
Journal:  Bioorg Med Chem Lett       Date:  2008-04-08       Impact factor: 2.823

View more
  6 in total

1.  Structural and Functional Characterization of the Histidine Phosphatase Domains of Human Sts-1 and Sts-2.

Authors:  Weijie Zhou; Yue Yin; Alexandra S Weinheimer; Neena Kaur; Nick Carpino; Jarrod B French
Journal:  Biochemistry       Date:  2017-08-21       Impact factor: 3.162

Review 2.  Perspective: Tyrosine phosphatases as novel targets for antiplatelet therapy.

Authors:  Lutz Tautz; Yotis A Senis; Cécile Oury; Souad Rahmouni
Journal:  Bioorg Med Chem       Date:  2015-04-04       Impact factor: 3.641

3.  Protein Tyrosine Phosphatase Biochemical Inhibition Assays.

Authors:  Marek R Baranowski; Jiaqian Wu; Ye Na Han; Lester J Lambert; Nicholas D P Cosford; Lutz Tautz
Journal:  Bio Protoc       Date:  2022-09-20

4.  A cellular target engagement assay for the characterization of SHP2 (PTPN11) phosphatase inhibitors.

Authors:  Celeste Romero; Lester J Lambert; Douglas J Sheffler; Laurent J S De Backer; Dhanya Raveendra-Panickar; Maria Celeridad; Stefan Grotegut; Socorro Rodiles; John Holleran; Eduard Sergienko; Elena B Pasquale; Nicholas D P Cosford; Lutz Tautz
Journal:  J Biol Chem       Date:  2020-01-17       Impact factor: 5.157

5.  Functional Analysis of Protein Tyrosine Phosphatases in Thrombosis and Hemostasis.

Authors:  Souad Rahmouni; Alexandre Hego; Céline Delierneux; Odile Wéra; Lucia Musumeci; Lutz Tautz; Cécile Oury
Journal:  Methods Mol Biol       Date:  2016

6.  An allosteric site on MKP5 reveals a strategy for small-molecule inhibition.

Authors:  Zachary T K Gannam; Kisuk Min; Shanelle R Shillingford; Lei Zhang; James Herrington; Laura Abriola; Peter C Gareiss; Georgios Pantouris; Argyrios Tzouvelekis; Naftali Kaminski; Xinbo Zhang; Jun Yu; Haya Jamali; Jonathan A Ellman; Elias Lolis; Karen S Anderson; Anton M Bennett
Journal:  Sci Signal       Date:  2020-08-25       Impact factor: 9.517

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.